Novo Nordisk A/S’s Interim Financial Report for the Period 1 January 2010 to 30 September 2010

BAGSVAERD, DENMARK--(Marketwire - October 27, 2010) -

Novo Nordisk’s operating profit up by 24% in the first nine months of 2010

Sales grew by 17% driven by Victoza®, NovoRapid® and Levemir®

[HUG#1455620]

Company Announcement no 60 2010:

http://hugin.info/2013/R/1455620/395476.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE